When should I start getting mammograms?

You should start getting mammograms at age 40 according to current ACR and ACOG guidelines, with annual or biennial frequency depending on risk. The USPSTF now also recommends starting at 40. Women with BRCA mutations or strong family history often start as early as age 25 to 30 with MRI, mammogram, or both.

What does "dense breast tissue" mean?

"Dense breast tissue" means your breasts have more glandular and connective tissue than fatty tissue, which makes mammograms harder to read because dense tissue and tumors both appear white. Pennsylvania law requires breast density notification on every mammogram report. Dense tissue is a small independent risk factor and a meaningful imaging-quality factor.

What is the difference between 2D and 3D mammography?

The difference between 2D and 3D mammography is the number of images. 2D produces flat top-and-side views. 3D (tomosynthesis) takes multiple thin slices that the radiologist scrolls through, reducing tissue overlap and improving cancer detection, especially in dense breasts.

Should I get a breast MRI in addition to a mammogram?

You should consider a breast MRI in addition to a mammogram if your lifetime breast cancer risk is 20 percent or higher, you have a BRCA mutation, you had chest radiation between ages 10 and 30, or your breasts are extremely dense. We calculate your risk using the Tyrer-Cuzick or BRCAPRO models.

What is a DEXA scan and why do women need it?

A DEXA scan is a low-dose X-ray that measures bone mineral density. Women need it because estrogen drops at menopause cause rapid bone loss, raising the risk of osteoporosis and fragility fractures. Catching osteopenia early gives us years to intervene before the first fracture.

Will my insurance cover preventive imaging?

Insurance typically covers preventive imaging on the standard guideline schedule. Mammograms after age 40 and DEXA scans after age 65 are usually covered without copay under the ACA. MRI and earlier-than-guideline screening often require prior authorization and a documented risk reason.

How often should I do a self-exam?

You should do a breast self-awareness check monthly, ideally a few days after your period when tissue is least lumpy. The goal is not to substitute for screening but to know your normal. Any new persistent lump, dimpling, nipple discharge, or skin change deserves a prompt clinical exam.

What is the role of a clinical breast exam?

The role of a clinical breast exam is supplemental to imaging. The exam can catch lumps that imaging missed and triggers further workup when needed. It does not replace mammography. We perform clinical exams as part of your annual visit.

How does breast density affect cancer risk independently of imaging difficulty?

Breast density affects cancer risk independently of imaging difficulty by raising the relative risk modestly. Women with extremely dense breasts (BI-RADS D) have about 1.5 to 2 times the risk of women with mostly fatty breasts. Density is one of several risk factors we weigh, alongside family history, reproductive history, and genetics.

What is the Tyrer-Cuzick risk model?

The Tyrer-Cuzick risk model is a clinical calculator that estimates 10-year and lifetime breast cancer risk by integrating family history, reproductive factors, body mass index, breast density, and known mutations. We use it to identify women who qualify for supplemental MRI or risk-reducing medications like tamoxifen.

How do BRCA1 and BRCA2 mutations change screening?

BRCA1 and BRCA2 mutations change screening dramatically. We typically start annual breast MRI at age 25, alternating with mammography starting at 30. Pelvic ultrasound and CA-125 may be added for ovarian surveillance, although these are imperfect tools. Risk-reducing surgery (oophorectomy by 40 to 45, mastectomy as discussed) is on the table.

What is the role of contrast-enhanced mammography (CEM)?

The role of contrast-enhanced mammography (CEM) is an emerging alternative for high-risk patients who cannot tolerate MRI due to claustrophobia, pacemakers, or severe gadolinium reactions. CEM uses iodine contrast and standard mammography equipment. Sensitivity is comparable to MRI in early studies.

How does pregnancy and breastfeeding affect breast imaging?

Pregnancy and breastfeeding affect breast imaging because dense, lactating tissue makes mammograms harder to read. Ultrasound is the first-line imaging during pregnancy or active lactation. We avoid contrast MRI during pregnancy and use it cautiously during breastfeeding, with a brief pump-and-discard interval.

What is the difference between osteopenia and osteoporosis?

The difference between osteopenia and osteoporosis is the T-score. Osteopenia is a T-score between -1.0 and -2.5. Osteoporosis is a T-score below -2.5. Both signal increased fracture risk, with osteoporosis being more severe. Treatment depends on T-score, FRAX risk, and prior fractures.

How does menopause hormone therapy affect breast cancer risk?

Menopause hormone therapy affects breast cancer risk modestly when used for more than 5 years, especially with combined estrogen plus progestin. Estrogen alone in women without a uterus carries lower risk. The decision is individualized based on symptoms, age at menopause, family history, and personal preference.

What is "interval cancer" and why does it matter?

"Interval cancer" is breast cancer detected between scheduled mammograms, often within a year of a normal screen. Interval cancers tend to be more aggressive. They are the main reason we add MRI or 3D mammography for high-risk women, since these tools detect cancers that 2D mammograms miss.

How does pelvic MRI fit into women's preventive imaging?

Pelvic MRI fits into women's preventive imaging mainly for symptom workup, not routine screening. It is the gold standard for evaluating endometriosis, fibroids, adenomyosis, and complex ovarian masses. Routine pelvic MRI in healthy women is rarely indicated.

What is the role of CA-125 testing?

The role of CA-125 testing is limited as a screening tool because it produces false positives in many benign conditions like endometriosis and pelvic inflammation. It is more useful for monitoring known ovarian cancer or in high-risk BRCA carriers as part of a layered surveillance plan.

How does Fishtown Medicine approach hormone replacement therapy and screening?

Fishtown Medicine approaches hormone replacement therapy and screening as a partnership. We weigh symptoms, fracture risk, cardiovascular risk, and personal preference. Modern data, especially from the WHI reanalysis and KEEPS trial, supports HRT for many women in early menopause. We coordinate screening intensity with HRT decisions.

Why does Fishtown Medicine personalize screening timelines so heavily?

Fishtown Medicine personalizes screening timelines so heavily because the cost of one-size-fits-all screening is high. A high-risk woman screened on average-risk timelines can miss a curable cancer. An average-risk woman screened on high-risk timelines collects extra biopsies and stress. The right answer is the right timeline for your biology.

TL;DR · 30-second take

Women's preventive imaging includes mammograms (annual or biennial from 40), breast MRI for high-risk patients, DEXA scans for bone density (typically from 65 or earlier with risk factors), and pelvic ultrasound for symptoms. We personalize timing based on genetics, family history, breast density, and life stage rather than one-size-fits-all guidelines.

Women's Preventive Imaging Guide for Philadelphia Patients

Preventive imaging is the cornerstone of early detection. At Fishtown Medicine, we move beyond standard guidelines to personalize your screening timeline based on your genetics, family history, and personal values. Whether it is a mammogram, a DEXA scan, or a comprehensive women's audit, we make sure you have the highest-resolution data on your health. The standard guidelines work for the average woman. They do not work for the woman with dense breasts, a BRCA mutation, or early menopause. Personalization is the whole point.

What is the essential screening roadmap?

The essential screening roadmap is the evidence-based baseline we then personalize for you. Standard recommendations include:

Mammograms: Annually or every other year for women ages 40 to 74. Earlier and more frequent if there is a strong family history or a known genetic mutation.
DEXA scans: The gold standard for diagnosing osteoporosis. Typically starting at age 65, or earlier for women in early menopause, with low body weight, on chronic steroids, or with other risk factors.
Pelvic ultrasounds: Used to investigate pelvic pain, abnormal bleeding, or to check IUD placement. Not a routine screening test.
Cervical cancer screening: Pap smear and HPV testing on the standard guideline schedule, coordinated with your gynecologist.

Breast health: how do we move beyond 2D?

Breast health imaging moves beyond 2D mammograms whenever the basic mammogram cannot answer the clinical question. A standard mammogram is essential, but it is not the only tool. Depending on your tissue density and risk, we may add:

3D mammography (tomosynthesis): Slightly higher detection rate than 2D, especially in dense breasts. Now the standard at most modern centers.
Breast ultrasound: Used to clarify if a lump is a fluid-filled cyst or a solid mass, and as supplemental screening in dense breasts.
Breast MRI: The most sensitive screening tool, recommended for women with a 20-percent or higher lifetime risk, BRCA1/BRCA2 mutations, a history of chest radiation, or strong family history. We help facilitate the prior authorizations needed.
Contrast-enhanced mammography (CEM): An emerging option for high-risk women who cannot tolerate MRI.

Bone health: what is the role of the DEXA scan?

The role of the DEXA scan is to measure bone mineral density (BMD), the gold standard for diagnosing osteopenia and osteoporosis. Skeletal health is a key component of longevity, especially after menopause when bone loss accelerates.

We look at the T-score of your hip and spine, plus your FRAX score (10-year fracture risk).
We use this data to build your strength and resistance training plan so you maintain independent mobility throughout your life.
For women with significant bone loss, we discuss bisphosphonates, denosumab, or anabolic agents like teriparatide, alongside vitamin D, calcium, and protein optimization.

Guidance from the clinic

"Screening is not about looking for trouble. It is about gathering baseline data. If we find a density shift in your 40s or 50s, we have a wide window to intervene through nutrition, hormones, and movement. My goal is to use these tools so your healthspan matches your lifespan. We do not just follow the charts. We follow your data."

Actionable Steps for Preventive Defense

Do not skip the essentials.

Audit your density: If a mammogram noted "dense breasts," ask in the Ultralight app whether ultrasound or MRI is the right next step.
Anchor your DEXA: Get a baseline bone density scan within the first few years of menopause to track your rate of change.
Map your family history: Bring a clear three-generation history. Cancers, heart disease, age of diagnosis, all matter.
Report changes early: Any new lump, nipple discharge, or sudden pelvic pain needs a clinical exam, not a delay until next year's mammogram. Reach out immediately.

Key Takeaways

Mammograms typically start at 40 (earlier with high risk).
DEXA scans are essential for protecting against osteoporosis.
Breast MRI is the high-resolution option for high-risk patients.
Early detection is one of the most powerful tools in women's health longevity.

Scientific References

Monticciolo DL, et al. "Breast Cancer Screening for Women at Higher-Than-Average Risk." Journal of the American College of Radiology. 2018.
Cosman F, et al. "Clinician's Guide to Prevention and Treatment of Osteoporosis." Osteoporosis International. 2014.
Saadatmand S, et al. "MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc)." The Lancet Oncology. 2019.
Manchanda R, et al. "Cost-effectiveness of population-based BRCA1, BRCA2 mutation testing." JAMA Oncology. 2018.

Dr. Ash is a board-certified internal medicine physician specializing in preventive medicine and healthspan optimization at Fishtown Medicine in Philadelphia.

Fishtown Medicine | Diagnostics

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Schedule a Consult

Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right plan must be matched to your unique lab work, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, especially if you have chronic health conditions or are taking prescription medications.

Frequently Asked Questions

Common Questions

Deep-Dive Questions

Still have a question?

He answers personally. Usually within a few hours.